Human Microbiome Drug Targets: Modern Approaches in Disease Management
Dable-Tupas, Genevieve
Karunakaran, Rohini
C Lim, Peter Paul
B Otero, Maria Catherine
Human Microbiome Drug Targets: Modern Approaches in Disease Management presents fundamental information on the human microbiome, looking into the relationship between the microbiome and how it changes with specific diseases. Delving into the multifaceted roles of the microbiome in health and disease, the book's chapters discuss the role of the human microbiome in the pathophysiologic understanding of relevant diseases or disorders and their management. As changes in the human microbiome can provide clues to the probable cause and effect of diseases or disorders, as well as the impacts of therapy or intervention, this book is a welcomed addition to the existing research. Explaining how a better understanding of the microbiome and its impact on health and disease can pave the way for future discoveries leading to better health outcomes, this book will be of interest to drug developers, medicinal chemists, microbiologists, infectious disease specialists, biochemists, and students. Provides readers with background information on the human microbiome, its evolution, and current understandingIncludes chapters dedicated to the importance of the human microbiome as drugs and as drug targetsServes as a guide to drug developers working in pharma, biotech, and academia, bringing together the latest research on the topic INDICE: Part One: Foundational Information 1. Tracing the History of Microbiome Evolution 2. The Human Microbiome: An Overview 3. The GUT Microbiome 4. The Microbiome and One Health Approach 5. Overview of Human Microbiome and Drug Discovery Part Two: Human Microbiome in Health and Disease 6. Human Microbiome and Nutrition 7. Human Microbiome and Mental Health 8. Human Microbiome and Diabetes 9. Human Microbiome and Cancer and Cancer Therapy 10. Human Microbiome, Obesity and Cardiovascular Diseases 11. Human Microbiome and Respiratory Diseases 12. Human Microbiome and Liver Diseases 13. Human Microbiome and Neuro-Developmental Disorders 14. Human Microbiome and Inflammatory Diseases Part Three: Microbiome and Drug Discovery 15. The Human Microbiome as Drug Targets 16. Microbiome-Based Therapeutics (Including Probiotics, Prebiotics and Symbiotics) 17. Microbiome Metabolite Based Therapies 18. Role of Nanotechnology in Microbiome Drug Development 19. Microbiome-Based Therapies on Trial
- ISBN: 978-0-443-15435-5
- Editorial: Elsevier
- Encuadernacion: Rústica
- Páginas: 350
- Fecha Publicación: 01/10/2024
- Nº Volúmenes: 1
- Idioma: Inglés